tiprankstipranks
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
US Market
Want to see ENTA full AI Analyst Report?

Enanta Pharmaceuticals (ENTA) Technical Analysis

190 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Enanta Pharmaceuticals’s (ENTA) Moving Averages Convergence Divergence (MACD) indicator is 0.27, suggesting Enanta Pharmaceuticals is a Sell.
Enanta Pharmaceuticals’s (ENTA) 20-Day exponential moving average is 13.66, while Enanta Pharmaceuticals’s (ENTA) share price is $14.01, making it a Buy.
Enanta Pharmaceuticals’s (ENTA) 50-Day exponential moving average is 13.52, while Enanta Pharmaceuticals’s (ENTA) share price is $14.01, making it a Buy.

Enanta Pharmaceuticals (ENTA) Pivot Points

May 19, 2026, 12:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.38
13.70
13.88
14.20
14.38
14.70
14.88
Fibonacci
13.70
13.89
14.01
14.20
14.39
14.51
14.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enanta Pharmaceuticals (ENTA) Moving Averages

May 19, 2026, 12:28 AM
Period
Simple
Exponential
MA5
14.30Sell
14.14Sell
MA10
14.00Buy
13.94Buy
MA20
13.25Buy
13.66Buy
MA50
13.60Buy
13.52Buy
MA100
13.82Buy
13.08Buy
MA200
11.50Buy
11.22Buy
Enanta Pharmaceuticals’s (ENTA) 10-Day exponential moving average is 13.94, while Enanta Pharmaceuticals’s (ENTA) share price is $14.01, making it a Buy.
Enanta Pharmaceuticals’s (ENTA) 100-Day exponential moving average is 13.08, while Enanta Pharmaceuticals’s (ENTA) share price is $14.01, making it a Buy.
Enanta Pharmaceuticals’s (ENTA) stock price is $14.01 and Enanta Pharmaceuticals’s (ENTA) 50-day simple moving average is 13.60, creating a Buy signal.
Enanta Pharmaceuticals’s (ENTA) stock price is $14.01 and Enanta Pharmaceuticals’s (ENTA) 100-day simple moving average is 13.82, creating a Buy signal.
Enanta Pharmaceuticals’s (ENTA) stock price is $14.01 and Enanta Pharmaceuticals’s (ENTA) 200-day simple moving average is 11.50, creating a Buy signal.

Enanta Pharmaceuticals (ENTA) Technical Indicators

May 19, 2026, 12:28 AM
Name
Value
Implied Action
RSI (14)
55.97
Neutral
STOCH (9,6)
67.48
Neutral
STOCHRSI (14)
78.24
Neutral
MACD (12,26)
0.27
Sell
ADX (14)
16.00
Buy
Williams %R
-28.03
Buy
CCI (14)
79.57
Neutral
ATR (14)
0.74
-
Ultimate Oscillator
58.23
Neutral
ROC
15.02
Buy
Enanta Pharmaceuticals’s (ENTA) Relative Strength Index (RSI) is 55.97, creating a Neutral signal.
Enanta Pharmaceuticals’s (ENTA) Trend Strength Indicator (ADX) is 16.00, creating a Buy signal.
Enanta Pharmaceuticals’s (ENTA) Commodity Channel Index (CCI) is 79.57, creating a Neutral signal.
Enanta Pharmaceuticals’s (ENTA) Price Rate of Change (ROC) is 15.02, creating a Buy signal.

FAQ

Is ENTA a Buy, Hold, or Sell?
Based on ENTA’s technical indicators, ENTA is a Buy.
    What is ENTA’s RSI (14)?
    ENTA’s RSI (14) is 55.97, which suggests ENTA is a Neutral.
      What is ENTA’s MACD?
      ENTA’s MACD is 0.27, which suggests ENTA is a Sell.
        What is ENTA’s 5-day moving average?
        ENTA’s 5-day moving average is 14.30, which suggests ENTA is a Sell.
          What is ENTA’s 20-day moving average?
          ENTA 20-day moving average is 13.25, which suggests ENTA is a Buy.
            What is ENTA’s 50-day moving average?
            ENTA’s 50-day moving average is 13.60, which suggests ENTA is a Buy.
              What is ENTA’s 200-day moving average?
              ENTA’s 200-day moving average is 11.50, which suggests ENTA is a Buy.
                What is ENTA’s Williams % R (14)?
                ENTA’s Williams % R (14) is -28.03, which suggests ENTA is a Buy.
                  What is ENTA’s CCI (14)?
                  ENTA’s CCI (14) is 79.57, which suggests ENTA is a Neutral.